CD274 and non-small cell lung carcinoma: For instance, a clinical trial evaluated the impact of antibiotic exposure on the clinical outcomes of non-small cell lung cancer (NSCLC) patients receiving anti-PD(L)−1 inhibitors combined with platinum.